• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿尔茨海默病的临床和病理进展过程中,皮质默认模式网络中的囊泡谷氨酸转运体变化。

Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.

机构信息

Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.

出版信息

J Alzheimers Dis. 2023;94(1):227-246. doi: 10.3233/JAD-221063.

DOI:10.3233/JAD-221063
PMID:37212097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10994206/
Abstract

BACKGROUND

Altered glutamatergic neurotransmission may contribute to impaired default mode network (DMN) function in Alzheimer's disease (AD). Among the DMN hub regions, frontal cortex (FC) was suggested to undergo a glutamatergic plasticity response in prodromal AD, while the status of glutamatergic synapses in the precuneus (PreC) during clinical-neuropathological AD progression is not known.

OBJECTIVE

To quantify vesicular glutamate transporter VGluT1- and VGluT2-containing synaptic terminals in PreC and FC across clinical stages of AD.

METHODS

Unbiased sampling and quantitative confocal immunofluorescence of cortical VGluT1- and VGluT2-immunoreactive profiles and spinophilin-labeled dendritic spines were performed in cases with no cognitive impairment (NCI), mild cognitive impairment (MCI), mild-moderate AD (mAD), or moderate-severe AD (sAD).

RESULTS

In both regions, loss of VGluT1-positive profile density was seen in sAD compared to NCI, MCI, and mAD. VGluT1-positive profile intensity in PreC did not differ across groups, while in FC it was greater in MCI, mAD, and sAD compared to NCI. VGluT2 measures were stable in PreC while FC had greater VGluT2-positive profile density in MCI compared to sAD, but not NCI or mAD. Spinophilin measures in PreC were lower in mAD and sAD compared to NCI, while in FC they were stable across groups. Lower VGluT1 and spinophilin measures in PreC, but not FC, correlated with greater neuropathology.

CONCLUSION

Frank loss of VGluT1 in advanced AD relative to NCI occurs in both DMN regions. In FC, an upregulation of VGluT1 protein content in remaining glutamatergic terminals may contribute to this region's plasticity response in AD.

摘要

背景

谷氨酸能神经传递的改变可能导致阿尔茨海默病(AD)中默认模式网络(DMN)功能受损。在 DMN 枢纽区域中,额叶皮层(FC)在 AD 前驱期被认为经历了谷氨酸能可塑性反应,而在临床-神经病理学 AD 进展过程中,楔前叶(PreC)的谷氨酸能突触状态尚不清楚。

目的

定量 AD 各临床阶段 PreC 和 FC 中囊泡谷氨酸转运体 VGluT1 和 VGluT2 包含的突触末端。

方法

在无认知障碍(NCI)、轻度认知障碍(MCI)、轻度中度 AD(mAD)或中度重度 AD(sAD)病例中,进行皮质 VGluT1 和 VGluT2 免疫反应性轮廓和 spinophilin 标记的树突棘的无偏采样和定量共聚焦免疫荧光。

结果

在两个区域,sAD 中 VGluT1 阳性轮廓密度的丧失均高于 NCI、MCI 和 mAD。PreC 中 VGluT1 阳性轮廓强度在各组之间没有差异,而在 FC 中,MCI、mAD 和 sAD 均高于 NCI。在 PreC 中 VGluT2 测量值稳定,而在 FC 中,MCI 中 VGluT2 阳性轮廓密度高于 sAD,但低于 NCI 或 mAD。PreC 中的 spinophilin 测量值在 mAD 和 sAD 中低于 NCI,而在 FC 中各组之间稳定。PreC 中较低的 VGluT1 和 spinophilin 测量值与较大的神经病理学相关,而在 FC 中则与各组无相关性。

结论

与 NCI 相比,AD 晚期 FC 和 DMN 两个区域中均出现 VGluT1 的明显丧失。在 FC 中,剩余谷氨酸能末梢中 VGluT1 蛋白含量的上调可能导致该区域在 AD 中的可塑性反应。

相似文献

1
Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.在阿尔茨海默病的临床和病理进展过程中,皮质默认模式网络中的囊泡谷氨酸转运体变化。
J Alzheimers Dis. 2023;94(1):227-246. doi: 10.3233/JAD-221063.
2
Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.阿尔茨海默病皮质中淀粉样β优先积聚在突触前谷氨酸能末梢(VGluT1 和 VGluT2)。
Neurobiol Dis. 2012 Jan;45(1):381-7. doi: 10.1016/j.nbd.2011.08.027. Epub 2011 Sep 3.
3
Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.楔前叶中对亲棘蛋白呈免疫阳性的树突棘缺失与早期阿尔茨海默病的认知障碍有关。
Neurobiol Aging. 2017 Jul;55:159-166. doi: 10.1016/j.neurobiolaging.2017.01.022. Epub 2017 Feb 4.
4
Developmental up-regulation of vesicular glutamate transporter-1 promotes neocortical presynaptic terminal development.发育上调囊泡谷氨酸转运体-1 促进新皮层突触前末梢发育。
PLoS One. 2012;7(11):e50911. doi: 10.1371/journal.pone.0050911. Epub 2012 Nov 30.
5
Telomeric alterations in the default mode network during the progression of Alzheimer's disease: Selective vulnerability of the precuneus.阿尔茨海默病进展过程中默认模式网络的端粒改变:楔前叶的选择性易损性。
Neuropathol Appl Neurobiol. 2021 Apr;47(3):428-440. doi: 10.1111/nan.12672. Epub 2020 Dec 5.
6
Vesicular glutamate transporter 1 and vesicular glutamate transporter 2 synapses on cholinergic neurons in the sublenticular gray of the rat basal forebrain: a double-label electron microscopic study.大鼠基底前脑舌下灰色区胆碱能神经元上的囊泡谷氨酸转运体 1 和囊泡谷氨酸转运体 2 突触:双重标记电子显微镜研究。
Neuroscience. 2009 Dec 29;164(4):1721-31. doi: 10.1016/j.neuroscience.2009.09.042. Epub 2009 Sep 22.
7
Alzheimer's Disease-associated Region-specific Decrease of Vesicular Glutamate Transporter Immunoreactivity inthe Medial Temporal Lobe and Superior Temporal Gyrus.阿尔茨海默病相关的内侧颞叶和颞上回区域特异性囊泡谷氨酸转运体免疫反应下降。
Neuroscience. 2024 May 14;546:75-87. doi: 10.1016/j.neuroscience.2024.03.027. Epub 2024 Mar 27.
8
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.前额叶皮质中VGLUT1和VGLUT2的缺失与阿尔茨海默病的认知衰退相关。
Neurobiol Aging. 2008 Nov;29(11):1619-30. doi: 10.1016/j.neurobiolaging.2007.04.010. Epub 2007 May 24.
9
Axon terminals expressing vesicular glutamate transporter VGLUT1 or VGLUT2 within the trigeminal motor nucleus of the rat: origins and distribution patterns.大鼠三叉神经运动核内表达囊泡谷氨酸转运体VGLUT1或VGLUT2的轴突终末:起源与分布模式
J Comp Neurol. 2009 Feb 10;512(5):595-612. doi: 10.1002/cne.21894.
10
Changes of immunocytochemical localization of vesicular glutamate transporters in the rat visual system after the retinofugal denervation.视网膜神经纤维切断术后大鼠视觉系统中囊泡型谷氨酸转运体免疫细胞化学定位的变化。
J Comp Neurol. 2003 Oct 13;465(2):234-49. doi: 10.1002/cne.10848.

引用本文的文献

1
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies.神经退行性疾病中的N-甲基-D-天冬氨酸受体:机制与新兴治疗策略
Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.
2
Excitatory neuron-prone prion propagation and excitatory neuronal loss in prion-infected mice.朊病毒感染小鼠中兴奋性神经元易感性朊病毒传播与兴奋性神经元丢失
Front Mol Neurosci. 2024 Dec 12;17:1498142. doi: 10.3389/fnmol.2024.1498142. eCollection 2024.
3
Synergistic effects of plasma-activated medium in combination with Baicalin against neuronal damage.

本文引用的文献

1
Neuropathology of Dementia Disorders.痴呆障碍的神经病理学。
Continuum (Minneap Minn). 2022 Jun 1;28(3):834-851. doi: 10.1212/CON.0000000000001137.
2
Recent update on the heterogeneity of the Alzheimer's disease spectrum.阿尔茨海默病谱异质性的最新研究进展。
J Neural Transm (Vienna). 2022 Jan;129(1):1-24. doi: 10.1007/s00702-021-02449-2. Epub 2021 Dec 17.
3
Postmortem Neocortical H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer's Disease.唐氏综合征和散发性阿尔茨海默病患者死后新皮层H-PiB结合以及未修饰和焦谷氨酸化β-淀粉样蛋白水平
血浆激活介质与黄芩苷联合对神经元损伤的协同作用。
Heliyon. 2024 Aug 11;10(16):e36079. doi: 10.1016/j.heliyon.2024.e36079. eCollection 2024 Aug 30.
4
Application of robust regression in translational neuroscience studies with non-Gaussian outcome data.稳健回归在具有非高斯结果数据的转化神经科学研究中的应用。
Front Aging Neurosci. 2024 Jan 24;15:1299451. doi: 10.3389/fnagi.2023.1299451. eCollection 2023.
5
Glaucoma Animal Models beyond Chronic IOP Increase.青光眼动物模型的研究进展:超越慢性眼压升高。
Int J Mol Sci. 2024 Jan 11;25(2):906. doi: 10.3390/ijms25020906.
Front Aging Neurosci. 2021 Aug 13;13:728739. doi: 10.3389/fnagi.2021.728739. eCollection 2021.
4
Dissociations between glucose metabolism and blood oxygenation in the human default mode network revealed by simultaneous PET-fMRI.同步 PET-fMRI 揭示人类默认模式网络中葡萄糖代谢与血氧水平的解偶联。
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27). doi: 10.1073/pnas.2021913118.
5
What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia.什么是“阿尔茨海默病”?临床上定义的阿尔茨海默病痴呆的神经病理学异质性。
Curr Opin Neurol. 2021 Apr 1;34(2):237-245. doi: 10.1097/WCO.0000000000000912.
6
The development and convergence of co-pathologies in Alzheimer's disease.阿尔茨海默病共病的发生和趋同。
Brain. 2021 Apr 12;144(3):953-962. doi: 10.1093/brain/awaa438.
7
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.阿尔茨海默病弥散和核心淀粉样-β斑块中 PiB 和 flutemetamol 的死后分析。
Acta Neuropathol. 2020 Oct;140(4):463-476. doi: 10.1007/s00401-020-02175-1. Epub 2020 Aug 9.
8
Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases.I型囊泡谷氨酸转运体(VGLUT1)在神经系统疾病中作用的研究进展
Cell Biosci. 2020 Mar 4;10:26. doi: 10.1186/s13578-020-00393-4. eCollection 2020.
9
Neuropathological correlates of amyloid PET imaging in Down syndrome.唐氏综合征淀粉样蛋白 PET 成像的神经病理学相关性。
Dev Neurobiol. 2019 Jul;79(7):750-766. doi: 10.1002/dneu.22713. Epub 2019 Aug 17.
10
The neuropathological diagnosis of Alzheimer's disease.阿尔茨海默病的神经病理学诊断。
Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.